As of the latest Form 4 filed Jun 3, 2026.
What Exelixis Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 65 most recent filings for EXEL.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-01 | WYSZOMIERSKI JACK L Director | SSale | −3.92K | $50.55 | $198K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Eckhardt Sue Gail Director | SSale | −9.81K | $50.14 | $492K | Yes (planned) | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | PAPADOPOULOS STELIOS Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Heyman Tomas J. Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Eckhardt Sue Gail Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Smith Julie Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Freire Maria C Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Beckerle Mary C Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Oliver Bob Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | WYSZOMIERSKI JACK L Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | POSTE GEORGE Director | AAward | +8.37K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Aftab Dana EVP, Research and Development | SSale | −43.5K | $50.35 | $2.19M | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-20 | Haley Patrick J. EVP, Commercial | SSale | −32.1K | $49.81 | $1.60M | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | MORRISSEY MICHAEL President and CEO | GGift | +124K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | MORRISSEY MICHAEL, President and CEO | GGift | −124K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Senner Christopher J. EVP and CFO | SSale | −34.9K | $50.00 | $1.75M | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Hefti Brenda SVP and General Counsel | SSale | −6.63K | $50.21 | $333K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | MORRISSEY MICHAEL President and CEO | FTax | −128K | $51.10 | $6.57M | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Senner Christopher J. EVP and CFO | FTax | −40.9K | $51.10 | $2.09M | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Haley Patrick J. EVP, Commercial | FTax | −33.3K | $51.10 | $1.70M | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Hefti Brenda SVP and General Counsel | FTax | −6.41K | $51.10 | $328K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Aftab Dana EVP, Research and Development | FTax | −30.6K | $51.10 | $1.56M | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Beckerle Mary C Director | SSale | −7.71K | $48.45 | $374K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Beckerle Mary C, Director | MExercise | +3.86K | $23.24 | $89.6K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Freire Maria C Director | SSale | −20.6K | $46.00 | $949K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Freire Maria C, Director | MExercise | +20.6K | $19.77 | $408K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | POSTE GEORGE Director | SSale | −60.0K | $45.71 | $2.74M | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-06 | MORRISSEY MICHAEL President and CEO | GGift | −110K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Aftab Dana EVP, Research and Development | AAward | +52.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Senner Christopher J. EVP and CFO | AAward | +52.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Hefti Brenda SVP and General Counsel | AAward | +23.1K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Haley Patrick J. EVP, Commercial | AAward | +40.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | MORRISSEY MICHAEL President and CEO | AAward | +160K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-24 | MORRISSEY MICHAEL, President and CEO | GGift | −100K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-26 | 2026-02-24 | Aftab Dana EVP, Research and Development | SSale | −47.9K | $44.50 | $2.13M | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | Aftab Dana EVP, Research and Development | SSale | −29.9K | $44.35 | $1.32M | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | WYSZOMIERSKI JACK L Director | SSale | −99.6K | $44.01 | $4.38M | Yes (planned) | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | WYSZOMIERSKI JACK L, Director | MExercise | +20.6K | $19.77 | $408K | Yes (planned) | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | Smith Julie Director | SSale | −20.0K | $44.30 | $887K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | Smith Julie, Director | MExercise | +20.0K | $21.69 | $434K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | Smith Julie, Director | SSale | −44.1K | $44.50 | $1.96M | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | Smith Julie, Director | MExercise | +44.1K | $19.39 | $855K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | Smith Julie, Director | SSale | −42.4K | $43.33 | $1.84M | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | Smith Julie, Director | MExercise | +42.4K | $18.19 | $772K | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-18 | MORRISSEY MICHAEL President and CEO | GGift | +125K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-18 | MORRISSEY MICHAEL, President and CEO | GGift | −125K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-18 | Hefti Brenda SVP and General Counsel | SSale | −18.7K | $44.01 | $822K | Yes (planned) | Form 4 ↗ |
| 2026-02-18 | 2026-02-17 | Senner Christopher J. EVP and CFO | SSale | −30.6K | $43.67 | $1.34M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-17 | Haley Patrick J. EVP, Commercial | SSale | −64.8K | $43.50 | $2.82M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-17 | Haley Patrick J., EVP, Commercial | SSale | −3.04K | $43.84 | $133K | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-17 | MORRISSEY MICHAEL President and CEO | GGift | +251K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-17 | MORRISSEY MICHAEL, President and CEO | GGift | −251K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-15 | Senner Christopher J. EVP and CFO | FTax | −35.9K | $43.92 | $1.58M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-15 | Haley Patrick J. EVP, Commercial | FTax | −31.5K | $43.92 | $1.38M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-15 | MORRISSEY MICHAEL President and CEO | FTax | −120K | $43.92 | $5.29M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-15 | Aftab Dana EVP, Research and Development | FTax | −12.7K | $43.92 | $559K | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-15 | Aftab Dana, EVP, Research and Development | FTax | −26.5K | $43.92 | $1.16M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-15 | Hefti Brenda SVP and General Counsel | FTax | −5.43K | $43.92 | $238K | Yes (planned) | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | Senner Christopher J. EVP and CFO | SSale | −34.3K | $43.00 | $1.47M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | MORRISSEY MICHAEL President and CEO | FTax | −370K | $43.92 | $16.2M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | MORRISSEY MICHAEL, President and CEO | MExercise | +495K | $21.31 | $10.5M | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | Eckhardt Sue Gail Director | SSale | −3.86K | $43.79 | $169K | Yes (planned) | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | Oliver Bob Director | SSale | −21.2K | $43.90 | $929K | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | Oliver Bob, Director | SSale | −9.09K | $43.61 | $396K | No | Form 4 ↗ |
| 2026-02-18 | 2026-02-13 | Oliver Bob, Director | MExercise | +9.09K | $19.28 | $175K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also EXEL’s full analysis or the market-wide insider trading feed. The tabs above jump to EXEL’s other SEC data.
Source: SEC Form 4 filings for EXEL, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.